CTMX Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $1.42M ; Research and development $17.60M ; Operating expenses $25.20M ; Income tax $60.00K . 2026-03-31: Revenue $10.26M ; Research and development $19.24M ; Operating expenses $29.93M ; Income tax $59.00K . 2025-12-31: Revenue $663.00K* ; Research and development $21.23M* ; Operating expenses $28.59M* ; Income tax $54.00K* . 2025-09-30: Revenue $5.96M ; Research and development $15.30M ; Operating expenses $21.73M ; Income tax $58.00K . Counterparty Name Separate filed amounts; connecting flows are not established. Components and totals may overlap.
CTMX revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Amgen Inc $0.00 Astellas Pharma Inc $79.00K Bristol Myers Squibb Company $0.00 Modernatx Inc $0.00 Regeneron Pharmaceuticals Inc $1.34M Revenue $1.42M Operating expenses $25.20M Operating income -$23.78M Other income, net $18.00K Research & development $17.60M Pre-tax income -$20.61M Income tax $60.00K Net income -$20.67M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Research and development Operating expenses Income tax Net income 2026-06-30 $1.42M $17.60M $25.20M $60.00K -$20.67M 2026-03-31 $10.26M $19.24M $29.93M $59.00K -$18.25M 2025-12-31 $663.00K* $21.23M* $28.59M* $54.00K* -$26.51M* 2025-09-30 $5.96M $15.30M $21.73M $58.00K -$14.23M 2025-06-30 $18.66M $13.32M $19.94M $63.00K -$154.00K 2025-03-31 $50.92M $18.87M $28.30M $62.00K $23.52M 2024-09-30 $33.43M $21.37M $29.32M $61.00K $5.74M 2024-06-30 $25.11M $25.17M $33.57M $51.00K -$6.53M 2024-03-31 $41.46M $22.05M $29.81M $49.00K $13.79M 2023-09-30 $26.38M $16.45M $23.26M $2.82M $2.99M 2023-06-30 $24.72M $20.67M $28.07M $0.00 -$1.09M 2023-03-31 $23.50M $21.18M $29.15M $0.00 -$3.31M 2022-09-30 $11.15M $30.37M $40.86M $0.00 -$29.06M 2022-06-30 $12.85M $31.16M $42.91M $0.00 -$29.50M 2022-03-31 $9.04M $30.56M $41.10M $0.00 -$31.98M 2021-12-31 $11.13M $36.58M $46.03M (m) -$34.82M 2021-09-30 $9.19M $29.14M $40.23M (m) -$30.98M 2021-06-30 $8.79M $26.10M $35.49M (m) -$26.74M 2021-03-31 $8.20M $22.37M $31.60M (m) -$23.33M 2020-12-31 $7.08M $22.01M $31.15M (m) -$24.00M 2020-09-30 $7.47M $24.05M $32.68M $0.00 -$25.03M 2020-06-30 $6.99M $24.07M $32.75M $0.00 -$25.30M 2020-03-31 $46.90M $42.81M $52.39M -$13.91M $9.51M 2019-12-31 $8.28M (m) (m) (m) -$35.45M 2019-09-30 $10.71M $27.97M $36.43M $0.00 -$23.70M 2019-06-30 $9.01M $30.84M $40.25M $0.00 -$28.96M 2019-03-31 $29.48M $36.38M $46.05M -$6.00K -$14.12M 2018-12-31 $11.47M (m) (m) $8.91M -$32.23M 2018-09-30 $12.51M $27.55M $35.69M $2.50M -$23.43M 2018-06-30 $21.34M $25.55M $34.59M $1.79M -$13.45M 2018-03-31 $14.18M $22.46M $29.81M $1.10M -$15.49M 2017-12-31 $27.07M (m) (m) (m) $621.00K 2017-09-30 $24.14M $28.92M $35.17M -$19.00K -$10.25M 2017-06-30 $8.75M $28.08M $34.13M $26.00K -$25.22M 2017-03-31 $11.65M $14.58M $20.27M -$1.00K -$8.26M 2016-12-31 $6.27M (m) (m) (m) -$14.03M 2016-09-30 $3.45M $13.34M $18.37M $1.00K -$14.66M 2016-06-30 $3.09M $12.71M $17.35M $3.00K -$14.18M 2016-03-31 $2.22M $13.37M $18.41M $3.00K -$16.03M 2015-12-31 $1.99M (m) (m) (m) -$11.49M 2015-09-30 $1.94M $9.16M $13.21M $3.00K -$11.87M 2015-06-30 $2.04M $5.03M $7.58M $5.00K -$5.81M 2015-03-31 $1.74M $4.66M $6.61M (m) -$6.21M 2014-12-31 $1.86M (m) (m) (m) -$4.79M 2014-09-30 $1.92M $3.92M $5.38M (m) -$3.59M 2014-06-30 $666.00K (m) (m) (m) -$4.93M 2014-03-31 $635.00K (m) (m) (m) -$17.00M
Revenue and expense 6 month Period end Revenue Research and development Operating expenses Income tax Net income 2026-06-30 $11.68M $36.84M $55.13M $119.00K -$38.91M 2025-06-30 $69.58M $32.19M $48.24M $126.00K $23.37M 2024-06-30 $66.58M $47.22M $63.37M $101.00K $7.26M 2023-06-30 $48.22M $41.85M $57.22M $0.00 -$4.40M 2022-06-30 $21.89M $61.72M $84.01M $0.00 -$61.48M 2021-06-30 $16.99M $48.47M $67.09M (m) -$50.06M 2020-06-30 $53.88M $66.88M $85.13M -$13.91M -$15.79M 2019-06-30 $38.50M $67.21M $86.30M -$6.00K -$43.09M 2018-06-30 $35.52M $48.01M $64.41M $2.89M -$28.94M 2017-06-30 $20.41M $42.65M $54.39M $26.00K -$33.47M 2016-06-30 $5.32M $26.07M $35.76M $6.00K -$30.20M 2015-06-30 $3.79M $9.70M $14.20M $5.00K -$12.02M
Revenue and expense 9 month Period end Revenue Research and development Operating expenses Income tax Net income 2025-09-30 $75.54M $47.49M $69.97M $184.00K $9.14M 2024-09-30 $100.01M $68.59M $92.69M $162.00K $12.99M 2023-09-30 $74.61M $58.29M $80.48M $2.82M -$1.41M 2022-09-30 $33.04M $92.08M $124.87M $0.00 -$90.54M 2021-09-30 $26.18M $77.61M $107.32M (m) -$81.05M 2020-09-30 $61.35M $90.93M $117.81M -$13.91M -$40.82M 2019-09-30 $49.21M $95.18M $122.73M -$6.00K -$66.78M 2018-09-30 $48.03M $75.56M $100.09M $5.39M -$52.37M 2017-09-30 $44.55M $71.57M $89.56M $7.00K -$43.72M 2016-09-30 $8.77M $39.41M $54.13M $7.00K -$44.87M 2015-09-30 $5.72M $18.85M $27.40M $8.00K -$23.89M 2014-09-30 $3.22M $23.96M $28.32M (m) -$25.52M
Revenue and expense 12 month Period end Revenue Research and development Operating expenses Income tax Net income 2025-12-31 $76.20M $68.73M $98.56M $238.00K -$17.37M 2024-12-31 $138.10M $83.38M $113.11M $224.00K $31.87M 2023-12-31 $101.21M $77.68M $107.70M $3.89M -$569.00K 2022-12-31 $53.16M $111.65M $154.50M $0.00 -$99.32M 2021-12-31 $37.31M $114.19M $153.35M $0.00 -$115.87M 2020-12-31 $68.43M $112.94M $148.97M -$13.91M -$64.82M 2019-12-31 $26.90M $131.62M $168.38M -$427.00K -$132.82M 2018-12-31 $59.50M $103.87M $137.38M $14.30M -$84.60M 2017-12-31 $71.62M $92.28M $117.88M -$513.00K -$43.10M 2016-12-31 (m) $54.76M $74.63M -$19.00K -$58.90M 2015-12-31 $7.71M $28.36M $40.91M $10.00K -$35.37M 2014-12-31 $5.08M $28.30M $34.84M $10.00K -$30.31M 2013-12-31 $888.00K $10.89M $15.84M $10.00K -$15.14M